Controversy is brewing, again, about using generic versions of antiepileptic drugs for seizures

July 2007

Controversy is brewing, again, about using generic versions of antiepileptic drugs for seizures.

The FDA says the therapeutically equivalent generics are fine...even for drugs with a narrow therapeutic index.

But there is a new move to limit generic substitution on antiepileptic drugs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote